| Symbol |
Name |
|
ACTN1
|
actinin, alpha 1
|
|
ACTN4
|
actinin, alpha 4
|
|
ADAMTS2
|
ADAM metallopeptidase with thrombospondin type 1 motif, 2
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
ANGPT2
|
angiopoietin 2
|
|
BSG
|
basigin (Ok blood group)
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CCNA2
|
cyclin A2
|
|
CCND1
|
cyclin D1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
DAP3
|
death associated protein 3
|
|
DCTN1
|
dynactin 1
|
|
DSG3
|
desmoglein 3
|
|
EDN1
|
endothelin 1
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
FBLN2
|
fibulin 2
|
|
GDF15
|
growth differentiation factor 15
|
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
HAX1
|
HCLS1 associated protein X-1
|
|
HK1
|
hexokinase 1
|
|
HK2
|
hexokinase 2
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HMGB1
|
high mobility group box 1
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL6
|
interleukin 6
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
LAMA4
|
laminin, alpha 4
|
|
LOX
|
lysyl oxidase
|
|
LTB4R2
|
leukotriene B4 receptor 2
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFI2
|
antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5
|
|
MIA
|
melanoma inhibitory activity
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MYOF
|
myoferlin
|
|
NLGN1
|
neuroligin 1
|
|
PAX6
|
paired box 6
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PKP3
|
plakophilin 3
|
|
PPID
|
peptidylprolyl isomerase D
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PTK2
|
protein tyrosine kinase 2
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RB1
|
retinoblastoma 1
|
|
RHOA
|
ras homolog family member A
|
|
RP1L1
|
retinitis pigmentosa 1-like 1
|
|
S100A4
|
S100 calcium binding protein A4
|
|
SAT1
|
spermidine/spermine N1-acetyltransferase 1
|
|
SCRIB
|
scribbled planar cell polarity protein
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SHARPIN
|
SHANK-associated RH domain interactor
|
|
SIRT3
|
sirtuin 3
|
|
SPINK5
|
serine peptidase inhibitor, Kazal type 5
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TJP1
|
tight junction protein 1
|
|
TJP2
|
tight junction protein 2
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TP53
|
tumor protein p53
|
|
TTR
|
transthyretin
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TWIST2
|
twist family bHLH transcription factor 2
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
YAP1
|
Yes-associated protein 1
|
